(Q42953723)
Statements
Prospective evaluation of angiogenic, hypoxic and EGFR-related biomarkers in recurrent glioblastoma multiforme treated with cetuximab, bevacizumab and irinotecan (English)
Benedikte Hasselbalch
Helle Broholm
Ib Jarle Christensen
Kirsten Grunnet
Hans Skovgaard Poulsen
Marie-Thérése Stockhausen
1 August 2010
1 reference
1 reference
1 reference
1 reference